Why is UnitedHealth under Medicare fraud investigation?
How did Trump’s Middle East visit boost AI deals?
What caused Foot Locker’s stock to surge recently?
Why is Tesla’s chairwoman paid more than peers?
How will Calif. budget deficit affect immigrant health care?
Why is CoreWeave’s revenue soaring after IPO?
What impact will GOP tax bill have on Americans?
Why are Starbucks employees striking over dress code?
How did Boeing secure its largest-ever jet order?
FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors
benzinga.com/general/biotech/25/05/45418609/fda-approves-mercks-kidney-cancer-drug-for-rare-type-of-neuroendocrine-tumors
The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for adult and pediatric patients 12 years and older with locally advanced, unresectable, or metastatic pheochromocytoma or paraganglioma (PPGL).
This represents the first…
This story appeared on benzinga.com, 2025-05-14 19:17:45.